MDI Health

What MDI Health does

MDI Health is a private healthtech company that develops an AI-powered medication management SaaS platform for U.S. health plans and provider organizations. The company's core technology, branded the Artificial Pharmacology Intelligence (API) system, applies a multi-dimensional, context-based approach to analyze thousands of patient-specific parameters—including medications, lab values, conditions, demographics, medical history, and adherence patterns—to generate personalized, EMR-deliverable clinical recommendations at population scale. Validation of the API engine has been published in a peer-reviewed ScienceDirect study reporting 93% accuracy versus expert clinical panels, and an independent evaluation with Stanford Medicine's Healthcare AI Applied Research Team (HEA³RT) is in progress with expected completion in 2026.

The platform is structured around two primary solution modules, Cost of Care Reduction and Quality Improvement, supported by population health dashboards, risk stratification, and provider engagement tooling. It targets adverse drug events, polypharmacy mismanagement, and non-adherence, and is positioned to improve STAR ratings and reduce pharmacy and medical spend (the company cites approximately $2,000 PMPY savings for high-risk patients). Recommendations are delivered directly into provider EMRs, and a flagship partnership with VirtualHealth embeds the engine inside the HELIOS population health platform.

MDI Health sells through an enterprise B2B SaaS motion with quote-based, annual subscription contracts to Medicare Advantage, Medicaid, and Commercial health plans as well as to health systems and ACOs. The company is domiciled in Israel as MDI Health Technologies Ltd., maintains R&D in Tel Aviv, and has established a U.S. commercial headquarters in Los Angeles. To date, the company has raised approximately $26 million across a 2021 seed round and a 2023 Series A led by Intel Capital.

Name

MDI Health

Legal name

MDI Health Technologies Ltd.

Website

https://mdihealth.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

MDI Health provides an AI-powered SaaS platform that analyzes patient medication data to deliver personalized clinical recommendations, serving U.S. health plans and provider organizations to reduce adverse drug events and improve quality measures.

Ownership category

akta.pro rank

Product category

AI Medication Management Software

NAICS

General Medical and Surgical Hospitals (622110)

SIC

Services-Prepackaged Software (7372)

akta.pro industry

PRIMARYHLACAKAH

Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools

Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT

SECONDARYHLACAKAG

Specialty Pharmacy & Complex Therapy Management Platforms

Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT

Keywords

• AI medication management
• Polypharmacy management software
• Clinical decision support
• Population health analytics
• Pharmacy SaaS platform

Headquarters

HQ city

Los Angeles

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

1. SaaS Platform Subscription: B2B SaaS platform subscription model where health plans and provider organizations pay for access to the AI-powered medication management platform. Revenue is generated through annual or multi-year subscription contracts with enterprise healthcare organizations.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

Core offering

MDI Health provides an AI-powered medication management SaaS platform that analyzes thousands of medical and pharmacological parameters per patient to generate personalized clinical recommendations, risk stratification, and deprescribing insights for health plans and provider organizations. The platform includes modules for Cost of Care Reduction and Quality Improvement, integrating directly with provider EMRs to optimize medication regimens, prevent adverse drug events, and improve STAR ratings across at-risk populations.

Product overview

MDI Health offers a unified AI-powered medication management SaaS platform consisting of a core AI engine (Artificial Pharmacology Intelligence) that powers multiple integrated modules and features. The platform includes Cost of Care Reduction and Quality Improvement modules, complemented by Population Health Management, Personalized Clinical Recommendations, and Provider Engagement features. Together, these components enable health plans and providers to identify medication-related risks, generate personalized interventions, optimize drug regimens, reduce costs by approximately $2,000 PMPY, and improve STAR ratings across at-risk populations.

Differentiator

Problem solved

Functional benefit

Products and services

• AI-Powered Medication Management Platform A comprehensive SaaS platform that uses AI to analyze patient data and generate personalized clinical recommendations for medication optimization, risk stratification, and care gap closure across at-risk populations. Sold to health plans (Medicare Advantage, Medicaid, Commercial) and provider organizations (health systems, ACOs) on enterprise subscription contracts.
• Cost of Care Reduction A solution module focused on reducing Rx and medical spend through instant patient-level personalized analysis, automated prioritization, and ready-to-send clinical recommendations that optimize medication regimens and enable deprescribing. Targets health plans and providers seeking $2,000 PMPY savings.
• Quality Improvement

Quantifiable outcome

• 93% accuracy in risk stratification and actionable interventions compared to expert panel
• +5 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature5 records

Partnerships

Two partnerships are on record, tiered core and flagship.

• Stanford Medicine Healthcare AI Applied Research Team (HEA³RT)coreStrategic or Co-development Partner · 4 September 2025Research collaboration with Stanford Medicine's Healthcare AI Applied Research Team to evaluate MDI's Artificial Pharmacology Intelligence system. The study will review approximately 200 patients' 10+ years of medical and insurance data, with recommendations independently reviewed by a ground truth committee of three senior clinical pharmacists. Expected completion in 2026.
• VirtualHealthflagshipTechnology or Integration · 2 May 2024Partnership to integrate MDI Health's AI-powered medication management technology into VirtualHealth's HELIOS population health management platform. The integration enables HELIOS users to access MDI's comprehensive analysis and AI automation capabilities to reduce total cost of care for at-risk populations, improve STAR ratings, decrease hospitalizations, and prevent adverse drug events.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• RxAnte: RxAnte provides medication adherence analytics and predictive modeling for health plans and PBMs, helping target interventions to high-risk members. It is highly comparable as a payer-focused medication optimization SaaS platform.
• Arine: Arine is a San Francisco-based AI medication intelligence platform that partners with health plans to optimize medication therapy, improve STAR ratings, and reduce total cost of care. It is the closest direct competitor to MDI Health in terms of AI-driven medication management for payers.
• Medisafe: Medisafe offers a digital medication management platform combining patient-facing adherence tools with provider and payer dashboards. It overlaps with MDI Health's medication management mission, though with a stronger consumer app orientation.
• Synapse Medicine: Synapse Medicine is a French healthtech offering AI-powered medication reconciliation and decision support integrated into EHRs and e-prescribing workflows. It is comparable to MDI in applying AI to medication safety at the prescriber level.

Broad incumbents

• Tabula Rasa HealthCare (now CareVention HealthCare): Tabula Rasa HealthCare provides medication risk mitigation and pharmacotherapy management services, particularly for PACE programs and at-risk populations. It is a broader, established incumbent in medication management with a heavier services model than MDI's pure-SaaS approach.
• OptumRx (UnitedHealth Group): OptumRx is one of the largest pharmacy benefit managers in the US and increasingly bundles medication adherence and clinical decision support into its payer offerings. It is a broad incumbent whose in-house capabilities could compete with or complement MDI.
• CVS Caremark: CVS Caremark is a top-three US PBM operating Medication Therapy Management programs and adherence interventions at scale. It is a broad incumbent competing for the same health plan budgets MDI targets.
• DrFirst: DrFirst provides medication data, e-prescribing, and clinical decision support infrastructure widely integrated into EHRs and pharmacies. It is comparable as adjacent medication-management infrastructure rather than a head-to-head SaaS competitor.

Others

• Surescripts: Surescripts operates the dominant US health information network for e-prescribing and medication history, used by virtually every EHR and pharmacy. It is an enabling infrastructure provider rather than a competitor, but its data and network coverage shape the addressable market for MDI.

Emerging players

• Hume Health: Hume Health is an emerging player applying AI to medication safety and prescribing decision support. It is an early-stage company with partial overlap to MDI's medication management focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/mdi-health

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds4 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MDI Health